Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Benefits of lung cancer screening with CT questioned

24.03.2005


Annual screening with helical computed tomography (CT) can help radiologists detect lung cancers at their earliest, most curable stage, but has not been shown to reduce mortality from the disease, according to a study published in the April issue of the journal Radiology.



"What we’re finding with CT screening are more early-stage cancers. That could be good news--finding cancers that we’d otherwise find at a late stage," said the study’s lead author, Stephen J. Swensen, M.D., professor and chair of the Department of Radiology at Mayo Clinic in Rochester, Minn. "However, a number of these are probably non-lethal or slow-growing cancers that the patient would likely have died with and not from. Other cancers were so aggressive that early detection with CT did not make a difference."

Lung cancer is the leading cause of cancer death in both men and women in the United States, killing more people than breast, prostate and colon cancers combined, according to the American Cancer Society (ACS). ACS estimates that in 2005 there will be approximately 172,570 new cases of lung cancer diagnosed in the United States and 163,510 people will die from the disease.


While recent studies have focused on the benefits of early detection, the Mayo researchers looked more closely at the negative impact of CT screening, including over-diagnosis, expense, changes to quality of life, unnecessary surgical procedures and mortality. The study, funded in part by the National Cancer Institute, represents the most complete follow-up of the same group of patients of any published CT lung screening research.

Between January 1999 and May 2004, Dr. Swensen and colleagues studied 1,520 current and former smokers at high risk for lung cancer. The patient group contained 788 men and 732 women, age 50 or older (median age 59). All patients received an initial low-dose, helical CT examination, with annual screenings over the next four years. CT depicted 3,356 nodules in 1,118 (73.6 percent) of the patients. The researchers documented 68 primary lung cancers in 66 patients. Thirty-one of the tumors were detected at the initial screening and 34 at subsequent screenings. Three cancers were diagnosed by other means between screenings.

Approximately 69 percent of patients had at least one false-positive finding. False-positives are uncalcified lung nodules proved benign by observation or biopsy. Among the cancers identified through CT screening, false-positive rates ranged from 92.4 percent among nodules 4 millimeters or larger to 96.0 percent among all nodules. "Currently, half of lung nodules suspected of being cancerous that go to surgery outside of research study centers turn out to be benign," Dr. Swensen said.

Surgical intervention to diagnose these nodules is expensive and may impact quality of life and mortality. According to Dr. Swensen, a small percentage of patients will have chronic pain as a result of surgery, and the average mortality rate from lung cancer surgery ranges from 3 to 5 percent. "That’s a big price to pay if it’s a benign nodule," he said.

The researchers found no significant difference when comparing mortality rates demonstrated by this study to those of the Mayo Lung Project, a lung cancer screening trial conducted in the 1970s using chest radiography, lending support to their suggestion that while CT helps radiologists find more early-stage cancers, many of these are slow-growing tumors that probably would not have been lethal over the patient’s lifetime. "While there is still reason to hope that early detection of lung cancer with CT may save lives, our results lead us to be very cautious, because there’s a chance that we may be doing more harm than good," Dr. Swensen said.

No professional health organizations currently recommend CT screening for lung cancer.

Doug Dusik | EurekAlert!
Further information:
http://www.rsna.org

More articles from Health and Medicine:

nachricht New malaria analysis method reveals disease severity in minutes
14.08.2017 | University of British Columbia

nachricht New type of blood cells work as indicators of autoimmunity
14.08.2017 | Instituto de Medicina Molecular

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Fizzy soda water could be key to clean manufacture of flat wonder material: Graphene

Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.

As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...

Im Focus: Exotic quantum states made from light: Physicists create optical “wells” for a super-photon

Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.

Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...

Im Focus: Circular RNA linked to brain function

For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.

While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...

Im Focus: RAVAN CubeSat measures Earth's outgoing energy

An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.

The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...

Im Focus: Scientists shine new light on the “other high temperature superconductor”

A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.

Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Call for Papers – ICNFT 2018, 5th International Conference on New Forming Technology

16.08.2017 | Event News

Sustainability is the business model of tomorrow

04.08.2017 | Event News

Clash of Realities 2017: Registration now open. International Conference at TH Köln

26.07.2017 | Event News

 
Latest News

A Map of the Cell’s Power Station

18.08.2017 | Life Sciences

Engineering team images tiny quasicrystals as they form

18.08.2017 | Physics and Astronomy

Researchers printed graphene-like materials with inkjet

18.08.2017 | Materials Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>